Abstract:Photodynamic therapy (PDT) has emerged as a promising approach for tumor treatment. However, traditional type II PDT faces limitations due to its oxygen-dependent nature. Type-I photosensitizers (PSs) exhibit superiority over conventional type-II PSs owing to their diminished oxygen dependence. Nevertheless, designing effective type-I PSs remains a significant challenge. In this work, we provide a novel strategy to tune the PDT mechanism of an exited photosensitizer through aryl substituent engineering. Using S-rhodamine as the base structure, three PSs were synthesized by incorporating phenyl, furyl, or thienyl groups at the meso position. Interestingly, furyl- or thienyl-substituted S-rhodamine are type-I-dominated PSs that produce O2•−, while phenyl S-rhodamine results in O2•− and 1O2 through type-I and type-II mechanisms, respectively. Experimental analyses and theoretical calculations showed that the introduction of a five-membered heterocycle at the meso position promoted intersystem crossing (ISC) and electron transfer, facilitating the production of O2•−. Furthermore, furyl- or thienyl-substituted S-rhodamine exhibited high phototoxicity at ultralow concentrations. Thienyl-substituted S-rhodamine showed promising PDT efficacy against hypoxic solid tumors. This innovative strategy provides an alternative approach to developing new type-I PSs without the necessity for creating entirely new skeletons.

Rational Design of Modified Oxobacteriochlorins as Potential Photodynamic Therapy Photosensitizers

Rational design by DFT calculations of new metal complexes for photodynamic therapy based on an H 2 O 2 -Responsive Ir(III) photosensitizer activatable in physiological environment

First-principles design of heavy-atom-free singlet oxygen photosensitizers for photodynamic therapy

Rational design of type-I photosensitizer molecules for mitochondrion-targeted photodynamic therapy

Sulphur- and Selenium-for-Oxygen Replacement as a Strategy to Obtain Dual Type I/Type II Photosensitizers for Photodynamic Therapy

Rational Design of Bioavailable Photosensitizers for Manipulation and Imaging of Biological Systems

Regulating 1 O 2 generation from heavy-atom-free triplet photosensitizers based on thiophene-fused BODIPY

Site-selected thionated benzothioxanthene chromophores as heavy-atom-free small-molecule photosensitizers for photodynamic therapy

Rational Design of Efficient Organic Phototherapeutic Agents Via Perturbation Theory for Enhancing Anticancer Therapeutics

On the antibacterial photodynamic inactivation mechanism of Emodin and Dermocybin natural photosensitizers: A theoretical investigation

Rational design of β-carboline as an efficient type I/II photosensitizer to enable hypoxia-tolerant chemo-photodynamic therapy

In Silico Investigation of a Series of D-A-D Structured Chain Thiophene Photosensitizers for Photodynamic Therapy

Chalcogen atom effect on the intersystem crossing kinetic constant of oxygen‐ and sulfur disubstituted heteroporphyrins

Exploring BODIPY Derivatives as Singlet Oxygen Photosensitizers for PDT

Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia.

Theoretical Investigation of Novel Nitrogen-Heterocyclic Iridium(III) Polypyridyl Complexes as Photosensitizers for Two-Photon Photodynamic Therapy

Heavy Atom-Free Triplet Photosensitizers: Molecular Structure Design, Photophysical Properties and Application in Photodynamic Therapy

Theoretical Investigation on Quinoline-Based Platinum (II) Complexes As Efficient Singlet Oxygen Photosensitizers in Photodynamic Therapy

Dipyrrinato‐Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation

New Cyclometalated Transition-Metal Based Photosensitizers for Singlet Oxygen Generation and Photodynamic Therapy

New Designs for Phototherapeutic Transition Metal Complexes